Preoperative risk factors for skeletal muscle mass loss in patients with biliary tract cancer
Journal of Hepato-Biliary-Pancreatic Sciences · 2024
DOI: 10.1002/jhbp.12006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2024. Verfasst von Ryo Sugiura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Sarcopenia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Endoscopic retrograde cholangiography (ERC)‐related procedures, usually performed before biliary tract cancer (BTC) surgery, are associated with increased risk for various complications, which can cause sarcopenia. No study has previously elucidated the relationship between preoperative ERC‐related procedures and sarcopenia/skeletal muscle mass loss.
Methods
Patients with BTC who underwent radical surgical resection following ERC‐related procedures were included. Skeletal muscle mass was evaluated using the psoas muscle mass index (PMI), which was determined using computed tomography images, and the change in PMI before the initial pre‐ERC and surgery (ΔPMI) was calculated. Risk factors for advanced skeletal muscle mass loss, defined as a large ΔPMI, were evaluated.
Results
The study cohort included 90 patients with a median age of 72 (interquartile range, 65–75) years. The median PMI pre‐ERC and surgery was 4.40 and 4.15 cm 2 /m 2 , respectively ( p < .01). The median ΔPMI was −6.2% (interquartile range, −10.9% to 0.5%). By multivariate analysis, post‐ERC pancreatitis and cholangitis before surgery were independent predictive factors for large PMI loss (odds ratio, 4.57 and 3.18, respectively; p = .03 and p = .02, respectively).
Conclusions
Skeletal muscle mass decreases preoperatively in most patients with BTC undergoing ERC. Post‐ERC pancreatitis and cholangitis before surgery were independent risk factors for large skeletal muscle mass loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Department of Gastroenterological Surgery II, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
ORCID-Profile: Ryo Sugiura, Masaki Kuwatani, Kazuma Kishi, Takehiro Noji
Zitieren
APA
Sugiura, R., Kuwatani, M., Kawakubo, K., Kishi, K., Yonemura, H., Nozawa, S., Ohara, M., Noji, T., Hirano, S., & Sakamoto, N. (2024). Preoperative risk factors for skeletal muscle mass loss in patients with biliary tract cancer. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.12006
Vancouver
Sugiura R, Kuwatani M, Kawakubo K, Kishi K, Yonemura H, Nozawa S, et al. Preoperative risk factors for skeletal muscle mass loss in patients with biliary tract cancer. Journal of Hepato-Biliary-Pancreatic Sciences. 2024. doi:10.1002/jhbp.12006
BibTeX
@article{Sugiura2024,
author = {Sugiura, Ryo and Kuwatani, Masaki and Kawakubo, Kazumichi and Kishi, Kazuma and Yonemura, Hiroki and Nozawa, Shunichiro and Ohara, Masatsugu and Noji, Takehiro and Hirano, Satoshi and Sakamoto, Naoya},
title = {Preoperative risk factors for skeletal muscle mass loss in patients with biliary tract cancer},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2024},
doi = {10.1002/jhbp.12006}
}
EUVIMED